Cite

HARVARD Citation

    Akinboye, E. et al. (2018). 2‐fluoro‐5‐maleimidobenzoic acid‐linked albumin drug (MAD) delivery for selective systemic targeting of metastatic prostate cancer. Prostate. 78 (9), pp. 655-663. [Online]. 
  
Back to record